Brief: Acer Therapeutics And Relief Therapeutics Announce Issuance Of U.S. Patent 11,154,521 Covering ACER-001 Formulation

MindMaze Therapeutics Holding SA

26/10/2021 13:36

Oct 26 (Reuters) - Acer Therapeutics Inc  ACER.O :
    * ACER THERAPEUTICS AND RELIEF THERAPEUTICS ANNOUNCE
ISSUANCE OF
U.S. PATENT 11,154,521 COVERING ACER-001 FORMULATION
    * ACER THERAPEUTICS INC - NEWLY ISSUED PATENT HAS AN
EXPIRATION
DATE IN 2036

Source text for Eikon:  ID:nGNX5gJ2Hg 
Further company coverage:  ACER.O